Privia Health Group (NASDAQ:PRVA) Director Sells $2,231,826.30 in Stock

Key Points

• Privia Health Group director Matthew Shawn Morris sold 88,110 shares on June 26 at an average price of $25.33, totaling about $2.23 million. The sale was made under a pre-arranged Rule 10b5-1 trading plan, and his ownership fell by 53.48% afterward.
• PRVA shares rose 0.7% to $25.73 in Tuesday trading, remaining near the top of their 12-month range of $18.77 to $26.51. The company’s market value is about $3.24 billion.
• Privia Health’s latest earnings beat expectations, with quarterly EPS of $0.19 versus the $0.08 estimate and revenue of $603.85 million versus $560.99 million expected. Analysts currently have a consensus rating of “Moderate Buy” with an average target price of $31.15.

Privia Health Group, Inc. (NASDAQ:PRVA - Get Free Report) Director Matthew Shawn Morris sold 88,110 shares of the business's stock in a transaction on Friday, June 26th. The shares were sold at an average price of $25.33, for a total value of $2,231,826.30. Following the completion of the sale, the director owned 76,651 shares in the company, valued at approximately $1,941,569.83. The trade was a 53.48% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Matthew Shawn Morris also recently made the following trade(s):

• On Monday, June 29th, Matthew Shawn Morris sold 63,212 shares of Privia Health Group stock. The shares were sold at an average price of $25.33, for a total value of $1,601,159.96.
• On Friday, May 1st, Matthew Shawn Morris sold 17,096 shares of Privia Health Group stock. The stock was sold at an average price of $24.99, for a total value of $427,229.04.
• On Monday, May 4th, Matthew Shawn Morris sold 1,017 shares of Privia Health Group stock. The stock was sold at an average price of $24.96, for a total value of $25,384.32.

Privia Health Group Stock Up 0.7%

Privia Health Group stock traded up $0.18 during midday trading on Tuesday, reaching $25.73. The stock had a trading volume of 863,376 shares, compared to its average volume of 928,529. Privia Health Group, Inc. has a 12 month low of $18.77 and a 12 month high of $26.51. The firm's 50-day moving average price is $23.22 and its 200 day moving average price is $22.95. The firm has a market capitalization of $3.24 billion, a PE ratio of 160.82, a P/E/G ratio of 2.02 and a beta of 0.90.

Privia Health Group (NASDAQ:PRVA - Get Free Report) last issued its earnings results on Thursday, May 7th. The company reported $0.19 earnings per share for the quarter, topping analysts' consensus estimates of $0.08 by $0.11. The firm had revenue of $603.85 million during the quarter, compared to analyst estimates of $560.99 million. Privia Health Group had a net margin of 0.97% and a return on equity of 2.81%. The company's quarterly revenue was up 25.8% on a year-over-year basis. During the same quarter last year, the business earned $0.22 earnings per share. Equities research analysts expect that Privia Health Group, Inc. will post 0.27 EPS for the current year.

Analyst Ratings Changes

A number of research firms recently weighed in on PRVA. Weiss Ratings lowered shares of Privia Health Group from a "hold (c)" rating to a "hold (c-)" rating in a research note on Friday, May 8th. Canaccord Genuity Group cut their price target on Privia Health Group from $35.00 to $34.00 and set a "buy" rating for the company in a report on Friday, May 8th. Citigroup reduced their price target on Privia Health Group from $34.00 to $32.00 and set a "buy" rating for the company in a research report on Tuesday, March 3rd. Barclays dropped their price objective on Privia Health Group from $25.00 to $24.00 and set an "equal weight" rating on the stock in a report on Tuesday, May 26th. Finally, Evercore set a $26.00 target price on Privia Health Group in a research note on Wednesday, April 8th. Eleven investment analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and a consensus target price of $31.15.

Institutional Trading of Privia Health Group

Several institutional investors and hedge funds have recently bought and sold shares of PRVA. Bayban bought a new position in shares of Privia Health Group in the fourth quarter worth $26,000. Hantz Financial Services Inc. boosted its stake in Privia Health Group by 456.2% during the fourth quarter. Hantz Financial Services Inc. now owns 1,129 shares of the company's stock valued at $27,000 after buying an additional 926 shares during the period. Global Retirement Partners LLC grew its position in Privia Health Group by 579.8% during the fourth quarter. Global Retirement Partners LLC now owns 1,584 shares of the company's stock worth $38,000 after buying an additional 1,351 shares in the last quarter. Canada Pension Plan Investment Board grew its position in Privia Health Group by 48.0% during the second quarter. Canada Pension Plan Investment Board now owns 3,700 shares of the company's stock worth $85,000 after buying an additional 1,200 shares in the last quarter. Finally, Kestra Advisory Services LLC bought a new position in Privia Health Group in the 4th quarter worth about $93,000. 94.48% of the stock is currently owned by hedge funds and other institutional investors.

About Privia Health Group

Privia Health Group NASDAQ: PRVA is a physician enablement company that partners with independent physicians, medical groups and health systems to transform the delivery of patient care. Through a clinically integrated network and a proprietary technology platform, the company supports providers in managing population health, delivering coordinated care and optimizing financial performance under both fee-for-service and value-based reimbursement models.

Founded in 2016 and headquartered in McLean, Virginia, Privia Health has rapidly expanded its footprint to serve multiple metropolitan markets across the United States.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.